InterventionsReview
Targeting Lipoprotein(a): A New Era in Cardiovascular Disease Prevention
Methodist DeBakey Cardiovascular Journal
- Lepodisiran
- Muvalaplin
- Lipid and ceramide metabolism
- Lipoprotein
- Atherosclerotic cardiovascular disease
- Humans
The paper
Bene-Alhasan Y, Nambi V, Abushamat LA et al.
Methodist DeBakey Cardiovascular Journal · 15 Sep 2026
